Exceptional Response to MEK Inhibition in a Patient With RAF1-Mutant Myxofibrosarcoma: Case Report and Mechanistic Overview.

Authors :: Özgü E
Aydin E
Adibi A
Tokat ÜM
Tutar O
Hu J
Demiray I
Kurzrock R
Demiray M
Source :: JCO precision oncology [JCO Precis Oncol] 2023 Sep; Vol. 7, pp. e2300299.
Publication Year :: 2023

Subjects :: Humans
Adult
Mitogen-Activated Protein Kinase Kinases
Proto-Oncogene Proteins c-raf
Fibrosarcoma drug therapy
Fibrosarcoma genetics

Full Text Access

Tools